|
|
||||||||




* Veterans Affairs Medical Center and
Department of Medicine, University of California, San Diego, CA 92161; and
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Canada
Microcrystals of calcium pyrophosphate dihydrate (CPPD) and monosodium urate (MSU) deposited in synovium and articular cartilage initiate joint inflammation and cartilage degradation in large part by binding and directly activating resident cells. TLRs trigger innate host defense responses to infectious pathogens, and the expression of certain TLRs by synovial fibroblasts has revealed the potential for innate immune responses to be triggered by mesenchymally derived resident cells in the joint. In this study we tested the hypothesis that chondrocytes also express TLRs and that one or more TLRs centrally mediate chondrocyte responsiveness to CPPD and MSU crystals in vitro. We detected TLR2 expression in normal articular chondrocytes and up-regulation of TLR2 in osteoarthritic cartilage chondrocytes in situ. We demonstrated that transient transfection of TLR2 signaling-negative regulator Toll-interacting protein or treatment with TLR2-blocking Ab suppressed CPPD and MSU crystal-induced chondrocyte release of NO, an inflammatory mediator that promotes cartilage degeneration. Conversely, gain-of-function of TLR2 in normal chondrocytes via transfection was associated with increased CPPD and MSU crystal-induced NO release. Canonical TLR signaling by parallel pathways involving MyD88, IL-1R-associated kinase 1, TNF receptor-associated factor 6, and I
B kinase and Rac1, PI3K, and Akt critically mediated NO release in chondrocytes stimulated by both CPPD and MSU crystals. We conclude that CPPD and MSU crystals critically use TLR2-mediated signaling in chondrocytes to trigger NO generation. Our results indicate the potential for innate immunity at the level of the articular chondrocyte to directly contribute to inflammatory and degenerative tissue reactions associated with both gout and pseudogout.
This article has been cited by other articles:
![]() |
H K Ea, V Monceau, E Camors, M Cohen-Solal, D Charlemagne, and F Liote Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals Ann Rheum Dis, November 1, 2008; 67(11): 1617 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q Zhang, W Hui, G J Litherland, M J Barter, R Davidson, C Darrah, S T Donell, I M Clark, T E Cawston, J H Robinson, et al. Differential Toll-like receptor-dependent collagenase expression in chondrocytes Ann Rheum Dis, November 1, 2008; 67(11): 1633 - 1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Heher, S. O. Thier, H. Rennke, and B. D. Humphreys Adverse Renal and Metabolic Effects Associated with Oral Sodium Phosphate Bowel Preparation Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1494 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. A. Brown, C. Peach, G. Russell, and B. P. Wordsworth Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis Rheumatology, April 1, 2007; 46(4): 586 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Scott, H. Ma, S. Viriyakosol, R. Terkeltaub, and R. Liu-Bryan Engagement of CD14 Mediates the Inflammatory Potential of Monosodium Urate Crystals J. Immunol., November 1, 2006; 177(9): 6370 - 6378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |